Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (51069) 51069
Book Chapter (2001) 2001
Newsletter (58) 58
Newspaper Article (55) 55
Magazine Article (15) 15
Book / eBook (11) 11
Reference (6) 6
Conference Proceeding (3) 3
Dissertation (3) 3
Transcript (3) 3
Book Review (2) 2
Trade Publication Article (2) 2
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (42776) 42776
humans (39500) 39500
life sciences & biomedicine (39299) 39299
female (24321) 24321
male (21084) 21084
oncology (20268) 20268
middle aged (19596) 19596
aged (16824) 16824
cancer (14987) 14987
tumors (14157) 14157
adult (12938) 12938
metastasis (10154) 10154
biological and medical sciences (9817) 9817
medical sciences (9558) 9558
prognosis (8709) 8709
surgery (8100) 8100
aged, 80 and over (7525) 7525
care and treatment (7238) 7238
animals (6814) 6814
analysis (6729) 6729
research (6521) 6521
chemotherapy (6320) 6320
immunohistochemistry (6048) 6048
squamous cell carcinoma (5979) 5979
neoplasm staging (5728) 5728
cell line, tumor (5702) 5702
treatment outcome (5692) 5692
pathology (5646) 5646
retrospective studies (5628) 5628
medicine & public health (5559) 5559
proteins (5349) 5349
lung cancer (5344) 5344
gene expression (5111) 5111
health aspects (5083) 5083
patients (4968) 4968
carcinoma (4946) 4946
hepatocellular carcinoma (4800) 4800
lung neoplasms - pathology (4704) 4704
apoptosis (4689) 4689
medical prognosis (4501) 4501
mice (4405) 4405
risk factors (4305) 4305
metastases (4285) 4285
cancer therapies (4278) 4278
development and progression (4024) 4024
liver cancer (3875) 3875
medicine (3815) 3815
genetic aspects (3746) 3746
abridged index medicus (3736) 3736
breast cancer (3736) 3736
carcinoma, squamous cell - pathology (3726) 3726
cell biology (3696) 3696
research article (3657) 3657
survival rate (3472) 3472
science & technology - other topics (3437) 3437
follow-up studies (3416) 3416
cell proliferation (3409) 3409
mutation (3363) 3363
diagnosis (3361) 3361
multidisciplinary sciences (3325) 3325
kinases (3308) 3308
lymphatic metastasis (3201) 3201
gene expression regulation, neoplastic (3045) 3045
lung cancer, non-small cell (3041) 3041
colorectal cancer (3015) 3015
studies (2988) 2988
hematology, oncology and palliative medicine (2857) 2857
disease-free survival (2825) 2825
carcinoma, non-small-cell lung - pathology (2779) 2779
survival analysis (2764) 2764
medical research (2763) 2763
colorectal carcinoma (2694) 2694
survival (2682) 2682
science (2671) 2671
liver neoplasms - pathology (2644) 2644
signal transduction (2573) 2573
lung neoplasms - drug therapy (2561) 2561
radiotherapy (2558) 2558
neoplasm invasiveness (2444) 2444
cell cycle (2423) 2423
biochemistry & molecular biology (2375) 2375
gastroenterology & hepatology (2354) 2354
antineoplastic agents - therapeutic use (2342) 2342
biomarkers (2331) 2331
cancer research (2298) 2298
carcinoma, non-small-cell lung - drug therapy (2246) 2246
cell growth (2240) 2240
carcinoma, hepatocellular - pathology (2232) 2232
radiology, nuclear medicine & medical imaging (2229) 2229
medicine, research & experimental (2208) 2208
research & experimental medicine (2205) 2205
kidney neoplasms - pathology (2186) 2186
antineoplastic combined chemotherapy protocols - therapeutic use (2174) 2174
breast neoplasms - pathology (2171) 2171
hepatoma (2115) 2115
kaplan-meier estimate (2066) 2066
radiation therapy (2065) 2065
biomarkers, tumor - metabolism (2057) 2057
young adult (2043) 2043
otorhinolaryngology (2012) 2012
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (52973) 52973
Japanese (186) 186
German (95) 95
French (93) 93
Spanish (44) 44
Polish (35) 35
Portuguese (31) 31
Chinese (30) 30
Italian (23) 23
Norwegian (22) 22
Russian (14) 14
Korean (6) 6
Danish (3) 3
Turkish (3) 3
Croatian (2) 2
Hungarian (2) 2
Romanian (2) 2
Amharic (1) 1
Arabic (1) 1
Czech (1) 1
Dutch (1) 1
Hebrew (1) 1
Latvian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
by Bradley, Jeffrey D, Prof and Paulus, Rebecca, BS and Komaki, Ritsuko, Prof and Masters, Gregory, MD and Blumenschein, George, Prof and Schild, Steven, Prof and Bogart, Jeffrey, Prof and Hu, Chen, PhD and Forster, Kenneth, PhD and Magliocco, Anthony, Prof and Kavadi, Vivek, MD and Garces, Yolanda I, MD and Narayan, Samir, MD and Iyengar, Puneeth, MD and Robinson, Cliff, MD and Wynn, Raymond B, Prof and Koprowski, Christopher, MD and Meng, Joanne, MD and Beitler, Jonathan, Prof and Gaur, Rakesh, MD and Curran, Walter, Prof and Choy, Hak, Prof
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 187 - 199
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Radiotherapy, Image-Guided | Chemoradiotherapy | Carcinoma, Large Cell - secondary | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Radiotherapy Dosage | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiotherapy, Conformal | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Chemotherapy | Dosage and administration | Lung cancer, Non-small cell | Antineoplastic agents | Radiotherapy | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Metastasis to the Thyroid Gland: Report of a Large Series from the Mayo Clinic
by Hegerova, Livia and Griebeler, Marcio L and Reynolds, Jordan P and Henry, Michael R and Gharib, Hossein
American journal of clinical oncology, ISSN 0277-3732, 08/2015, Volume 38, Issue 4, pp. 338 - 342
carcinoma | fine-needle aspiration | metastases to the thyroid | Life Sciences & Biomedicine | Oncology | Science & Technology | Thyroid Neoplasms - diagnosis | Melanoma - diagnosis | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Squamous Cell - diagnosis | Thyroid Neoplasms - therapy | Young Adult | Aged, 80 and over | Adult | Female | Retrospective Studies | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Carcinoma - secondary | Skin Neoplasms - pathology | Cross-Sectional Studies | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Carcinoma - diagnosis | Survival Rate | Thyroidectomy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Biopsy, Fine-Needle | Adenocarcinoma - diagnosis | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Carcinoma, Renal Cell - diagnosis | Carcinoma, Renal Cell - secondary | Carcinoma, Renal Cell - therapy | Thyroid Neoplasms - secondary | Carcinoma - therapy | Carcinoma, Squamous Cell - secondary | Kidney Neoplasms - pathology | Aged | Melanoma - therapy | Cohort Studies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450)
by De Ruysscher, Dirk and Wanders, Rinus and van Baardwijk, Angela and Dingemans, Anne-Marie C and Reymen, Bart and Houben, Ruud and Bootsma, Gerben and Pitz, Cordula and van Eijsden, Linda and Geraedts, Wiel and Baumert, Brigitta G and Lambin, Philippe
Journal of thoracic oncology, ISSN 1556-0864, 10/2012, Volume 7, Issue 10, pp. 1547 - 1555
Non–small-cell lung cancer | Chemotherapy | Combined modality treatment | Oligometastases | stage IV | Individualized | Radiotherapy | Non-small-cell lung cancer | Stage IV | Respiratory System | Oncology | Life Sciences & Biomedicine | Science & Technology | Prognosis | Prospective Studies | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Radiosurgery | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Carcinoma, Large Cell - secondary | Neoplasm Metastasis | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Time Factors | Aged, 80 and over | Adult | Female | Neoplasm Recurrence, Local - therapy | Risk Factors | Carcinoma, Squamous Cell - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer:: an open-label, multicentre phase 2 trial
by Planchard, David and Besse, Benjamin and Groen, Harry J. M and Souquet, Pierre-Jean and Quoix, Elisabeth and Baik, Christina S and Barlesi, Fabrice and Kim, Tae Min and Mazieres, Julien and Novello, Silvia and Rigas, James R and Upalawanna, Allison and D'Amelio, Anthony M and Zhang, Pingkuan and Mookerjee, Bijoyesh and Johnson, Bruce E
The lancet oncology, ISSN 1470-2045, 07/2016, Volume 17, Issue 7, pp. 984 - 993
HARBORING BRAF MUTATIONS | 1ST-LINE TREATMENT | MELANOMA | INHIBITION | AMPLIFICATION | ADENOCARCINOMAS | CRIZOTINIB | CHEMOTHERAPY | EGFR | V600 MUTATIONS | Life Sciences & Biomedicine | Oncology | Science & Technology | Carcinoma, Large Cell - drug therapy | Lung Neoplasms - drug therapy | Prognosis | Follow-Up Studies | Humans | Middle Aged | Oximes - administration & dosage | Imidazoles - administration & dosage | Neoplasm Recurrence, Local - drug therapy | Lung Neoplasms - pathology | Male | Neoplasm Recurrence, Local - pathology | Pyridones - administration & dosage | Carcinoma, Large Cell - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Adult | Female | Adenocarcinoma - genetics | Carcinoma, Large Cell - genetics | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Survival Rate | Lymphatic Metastasis | Mutation - genetics | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | Pyrimidinones - administration & dosage | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601)
by Decroisette, Chantal and Monnet, Isabelle and Berard, Henri and Quere, Gilles and Le Caer, Herve and Bota, Suzanna and Audigier-Valette, Clarisse and Geriniere, Laurence and Vernejoux, Jean-Marc and Chouaid, Christos and the Groupe Français de Pneumo-Cancérologie 0601 Team and Grp Francais Pneumocancerologie 06 and Groupe Français de Pneumo-Cancérologie 0601 Team
Journal of thoracic oncology, ISSN 1556-0864, 03/2011, Volume 6, Issue 3, pp. 576 - 582
Zoledronic acid | Costs | Bone metastases | Non-small cell lung cancer | Biphosphonates | Respiratory System | Oncology | Life Sciences & Biomedicine | Science & Technology | Markov Chains | Prospective Studies | Bone Neoplasms - therapy | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - secondary | Bone Neoplasms - epidemiology | Lung Neoplasms - pathology | Male | Small Cell Lung Carcinoma - secondary | Carcinoma, Large Cell - secondary | Carcinoma, Large Cell - epidemiology | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - economics | Aged, 80 and over | Diphosphonates - therapeutic use | Female | Retrospective Studies | Radiotherapy Dosage | France - epidemiology | Carcinoma, Squamous Cell - epidemiology | Carcinoma, Non-Small-Cell Lung - epidemiology | Carcinoma, Squamous Cell - therapy | Survival Rate | Treatment Outcome | Combined Modality Therapy | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - economics | Carcinoma, Non-Small-Cell Lung - therapy | Lung Neoplasms - epidemiology | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Large Cell - economics | Cost-Benefit Analysis | Health Care Costs - statistics & numerical data | Carcinoma, Squamous Cell - secondary | Aged | Bone Neoplasms - economics | Lung Neoplasms - economics | Small Cell Lung Carcinoma - therapy | Adenocarcinoma - economics | Adenocarcinoma - epidemiology | Neoplasm Staging | Small Cell Lung Carcinoma - epidemiology | Carcinoma, Large Cell - therapy | Small Cell Lung Carcinoma - economics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
by Giorgio Scagliotti and Silvia Novello and Joachim von Pawel and Martin Reck and José Rodrigues Pereira and Michael Thomas and José Elias Abrão Miziara and Beatrix Balint and Filippo De Marinis and Alan Keller and Osvaldo Arén and Maria Csollak and Istvan Albert and Carlos Henrique Barrios and Francesco Grossi and Maciej Krzakowski and Lisa Cupit and Frank Cihon and Sandra DiMatteo and Nasser Hanna
Journal of clinical oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 11, pp. 1835 - 1842
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Tumors | Pneumology | Niacinamide - analogs & derivatives | Carcinoma, Large Cell - drug therapy | Lung Neoplasms - drug therapy | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Phenylurea Compounds | Benzenesulfonates - administration & dosage | Carcinoma, Large Cell - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Aged, 80 and over | Placebos | Adult | Female | Paclitaxel - administration & dosage | Pyridines - administration & dosage | Carboplatin - administration & dosage | Survival Rate | Treatment Outcome | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Squamous Cell - secondary | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma
by Danit Lebanony and Hila Benjamin and Shlomit Gilad and Meital Ezagouri and Avital Dov and Karin Ashkenazi and Nir Gefen and Shai Izraeli and Gideon Rechavi and Harvey Pass and Daisuke Nonaka and Junjie Li and Yael Spector and Nitzan Rosenfeld and Ayelet Chajut and Dalia Cohen and Ranit Aharonov and Mahesh Mansukhani
Journal of clinical oncology, ISSN 0732-183X, 04/2009, Volume 27, Issue 12, pp. 2030 - 2037
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Tumors | Pneumology | Prognosis | Oligonucleotide Array Sequence Analysis | Carcinoma, Squamous Cell - genetics | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Carcinoma, Non-Small-Cell Lung - diagnosis | Gene Expression Profiling | Carcinoma, Squamous Cell - diagnosis | Carcinoma, Large Cell - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Aged, 80 and over | Adult | Biological Assay | Female | Adenocarcinoma - genetics | Carcinoma, Large Cell - genetics | Lung Neoplasms - genetics | Carcinoma, Large Cell - diagnosis | Carcinoma, Non-Small-Cell Lung - genetics | Reverse Transcriptase Polymerase Chain Reaction | Adenocarcinoma - secondary | Adenocarcinoma - diagnosis | Carcinoma, Squamous Cell - secondary | Aged | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Lung Neoplasms - diagnosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
by Goldberg, Sarah B, Dr and Gettinger, Scott N, MD and Mahajan, Amit, MD and Chiang, Anne C, MD and Herbst, Roy S, Prof and Sznol, Mario, Prof and Tsiouris, Apostolos John, MD and Cohen, Justine, DO and Vortmeyer, Alexander, MD and Jilaveanu, Lucia, MD and Yu, James, MD and Hegde, Upendra, MD and Speaker, Stephanie, BA and Madura, Matthew, BS and Ralabate, Amanda, BSN and Rivera, Angel, MS and Rowen, Elin, MSN and Gerrish, Heather, BSN and Yao, Xiaopan, PhD and Chiang, Veronica, MD and Kluger, Harriet M, Prof
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 976 - 983
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Carcinoma, Large Cell - drug therapy | Lung Neoplasms - drug therapy | Prognosis | Skin Neoplasms - drug therapy | Follow-Up Studies | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Brain Neoplasms - secondary | Carcinoma, Large Cell - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Female | Skin Neoplasms - pathology | Antibodies, Monoclonal, Humanized - therapeutic use | Survival Rate | Lymphatic Metastasis | Melanoma - pathology | Brain Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Melanoma - drug therapy | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Care and treatment | Metastasis | Lung cancer, Non-small cell | Immunotherapy | Analysis | Medical research | Medicine, Experimental | Information management | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic EGFR Mutations
by Lecia V. Sequist and Renato G. Martins and David Spigel and Steven M. Grunberg and Alexander Spira and Pasi A. Jänne and Victoria A. Joshi and David McCollum and Tracey L. Evans and Alona Muzikansky and Georgiana L. Kuhlmann and Moon Han and Jonathan S. Goldberg and Jeffrey Settleman and A. John Iafrate and Jeffrey A. Engelman and Daniel A. Haber and Bruce E. Johnson and Thomas J. Lynch
Journal of clinical oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 15, pp. 2442 - 2449
Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Tumors | Pneumology | Carcinoma, Large Cell - drug therapy | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Prospective Studies | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Central Nervous System Neoplasms - secondary | Carcinoma, Large Cell - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Carcinoma, Large Cell - genetics | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Central Nervous System Neoplasms - genetics | In Situ Hybridization, Fluorescence | Survival Rate | Treatment Outcome | Mutation - genetics | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease-Free Survival | Quinazolines - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Central Nervous System Neoplasms - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Distinct clinical features and outcomes in never‐smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement
by Kim, Hye Ryun and Shim, Hyo Sup and Chung, Jin‐Haeng and Lee, Young Joo and Hong, Yun Kyoung and Rha, Sun Young and Kim, Se Hoon and Ha, Sang‐Jun and Kim, Se Kyu and Chung, Kyung Young and Soo, Ross and Kim, Joo Hang and Cho, Byoung Chul
Cancer, ISSN 0008-543X, 02/2012, Volume 118, Issue 3, pp. 729 - 739
ALK | KRAS | never‐smoker | nonsmall cell lung carcinoma | EGFR | never-smoker | Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Tumors | Pneumology | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Prognosis | Lung Neoplasms - mortality | Carcinoma, Squamous Cell - genetics | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Carcinoma, Large Cell - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Adult | Female | Adenocarcinoma - genetics | Carcinoma, Large Cell - genetics | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Proto-Oncogene Proteins - genetics | Survival Rate | Mutation - genetics | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Receptor Protein-Tyrosine Kinases - genetics | Gene Rearrangement | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Adenocarcinoma - mortality | Smoking | Nonsmokers | Lung cancer, Non-small cell | Health aspects | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights